A Randomized, Double-Blinded, Double-Dummy, Active-Comparator Trial to Investigate the Efficacy,Safety, and Tolerability of Efgartigimod PH20 SC Compared to Rituximab in Adult Patients with Moderateor Severe Pemphigus (Vulgaris or Foliaceus)

Project: Research project

Project Details

Description

A Randomized, Double-Blinded, Double-Dummy, Active-Comparator Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC Compared to Rituximab in Adult Patients with Moderate or Severe Pemphigus (Vulgaris or Foliaceus)
StatusActive
Effective start/end date8/19/20 → 8/30/25

Funding

  • ARGENX

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint